Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.1413
+0.0094 (7.13%)
Jan 2, 2026, 3:53 PM EST - Market open
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $15.19 million as of January 2, 2026. Its market cap has decreased by -83.69% in one year.
Market Cap
15.19M
Enterprise Value
22.01M
1-Year Change
-83.69%
Ranking
Category
Stock Price
$0.14
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $15.19M, a decrease of -95.66%. That is a compound annual growth rate of -56.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 14.18M | -84.13% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
| Apr 11, 2022 | 349.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |